Robert Hryniewicki, an executive vice president at TTR Sotheby’s International Realty, talks about the recent uptick in ...

BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) had its price target increased by equities researchers at JPMorgan Chase & ...

American Century Companies Inc. lifted its position in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 9.6% in the 4th ...

In the Japanese Phase 3 study, 0% mortality was reported over the 30-month treatment period and acoramidis was well-toleratedThe approval was ...

In the Japanese Phase 3 study, 0% mortality was reported over the 30-month treatment period and acoramidis was well-tolerated The approval was based on a Japanese Phase 3 study and the global ...

In the Japanese Phase 3 study, 0% mortality was reported over the 30-month treatment period and acoramidis was well-tolerated In the Japanese Phase 3 study, 0% mortality was reported over the 30 ...

In the Japanese Phase 3 study, 0% mortality was reported over the 30-month treatment period and acoramidis was well-tolerated The approval was based on a Japanese Phase 3 study and the global ...

Since its launch in 2014, the Yamaha MT-07 has been one of the UK’s best loved bikes. It kick started a new chapter for the Japanese manufacturer; delivering a bike that set a new high in the ...

Alongside those results, WVE-N531 was able to elicit a 3.8-second difference in TTR versus a natural history of matched untreated patients, using the North Star Ambulatory Assessment (NSAA ...

The treatment, which is administered quarterly via subcutaneous injection, reduces the production of transthyretin (TTR), addressing the disease at its source. The approval is particularly ...

The Mazda CX-90 is a three-row midsize family SUV that debuted in 2024. I was impressed by the CX-90's spirited driving dynamics, luxurious cabin, and bold styling. I was less impressed by its ...